CAMBRIDGE, Mass., March 7, 2011 /PRNewswire/ -- Idenix
Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that
management will present a corporate overview at the Roth 23rd
Annual Growth Stock Conference on Monday,
March 14, 2011 at 12:00 p.m.
PT at the Ritz Carlton Laguna Niguel in Dana Point, California and at the Barclays
Capital 2011 Global Healthcare Conference on Thursday, March 17, 2011 at 11:15 a.m. ET at the Loews Miami Hotel,
Florida.
The live and archived webcasts of the company presentations can
be accessed under "Calendar of Events" in the Idenix Investor
Center at www.idenix.com. Please log in approximately 5-10
minutes before each event to ensure a timely connection. The
archived replays will be available on the Idenix website for two
weeks following the conferences.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development
of drugs for the treatment of human viral diseases. Idenix's
current focus is on the treatment of infections caused by the
hepatitis C virus. For further information about Idenix, please
refer to http://www.idenix.com.
|
Idenix Pharmaceuticals
Contact:
|
|
|
Kelly Barry (617) 995-9033
(media)
|
|
|
Eric Hoffman (617) 224-4485
(investors)
|
|
|
SOURCE Idenix Pharmaceuticals, Inc.